Totus Medicines

Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.

Health and bio

TIMELINE · MONEY RAISED

Totus Medicines | 615 days from website to first raise on record

@Totus_Medicines·Raised $106M in 2 sourced rounds·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. December 17, 2023
   Series B+ · $66M
   DDCVC Bio (lead), CCamford Capital, NNorthpond Ventures, RRegents of The University of Minnesota
   Source: startupintros.com
2. December 1, 2021
   Series A · $40M
   DDCVC Bio (lead), NNorthpond Ventures (lead), CCamford Capital, SSocial Impact Capital
   Source: startupintros.com
3. July 2, 2020
   X account created
4. March 26, 2020
   Website created

Founders and team

• JP
  Jason Pontin Founder

  @jason_pontin · LinkedIn
• JB
  Jimmy Blair Founder

  LinkedIn
• ND
  Neil Dhawan Founder

  @neil_dhawan · LinkedIn
• NU
  Nassim Usman President & CEO
• LD
  Laura Drum Miller CBO and COO
• SH
  Simon Harnest Chief Financial Officer
• ZG
  Zelanna Goldberg Chief Medical Officer

Investors

• CCamford Capital
• DDCVC Biolead investor
• DDHVC
• NNorthpond Ventureslead investor
• RRegents of The University of Minnesota
• SSocial Impact Capital

Companies like Totus Medicines

• MMatchpoint Therapeutics$150M Series B+ · Oct 2026
• TTerremotobioSeries B+ · Nov 2023
• RRenaissTheraSeed · Jun 2026
• MModel Medicines$4.1M · Nov 2021
• RRgenta TherapeuticsSeries B+ · Nov 2026
• EEnveda$311M Series B+ · Sep 2026

Other companies backed by DCVC Bio

• LLatus Bio$97M Series A · May 2026
• AAgZen$10M Series B+ · Mar 2026
• NNilo Therapeutics$101M Series A · Oct 2025
• GGrove Biopharma$30M Series A · Apr 2025
• UUmoja Biopharma$100M Series B+ · Jan 2025
• NnChroma Bio$75M · Dec 2024

DCVC Bio portfolio →